Ascend Wellness (AAWH) Stock Price, News & Analysis

Company Overview

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.

Key Stats

• Today's Range: $0.32 to $0.34
• 50-Day Range: $0.28 to $0.45
• 52-Week Range: $0.26 to $1.23
• Volume: 24,286 shs
• Average Volume: 115,683 shs
• Market Capitalization: $67.98 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Ascend Wellness Stock Analysis - MarketRank™

Ascend Wellness scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ascend Wellness.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Ascend Wellness are expected to grow in the coming year, from ($0.40) to ($0.21) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ascend Wellness is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ascend Wellness is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ascend Wellness has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Ascend Wellness has been sold short.

Short Interest Ratio / Days to Cover

Ascend Wellness has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ascend Wellness has recently increased by 167.54%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ascend Wellness does not currently pay a dividend.

Dividend Growth

Ascend Wellness does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.03% of the float of Ascend Wellness has been sold short.

Short Interest Ratio / Days to Cover

Ascend Wellness has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ascend Wellness has recently increased by 167.54%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: N/A

News Sentiment

Ascend Wellness has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ascend Wellness insiders have not sold or bought any company stock.

Percentage Held by Insiders

22.38% of the stock of Ascend Wellness is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 17.31% of the stock of Ascend Wellness is held by institutions.

AAWH Stock Analysis - Frequently Asked Questions

How have AAWH shares performed this year?

Ascend Wellness' stock was trading at $0.39 on January 1st, 2025. Since then, AAWH shares have decreased by 14.7% and is now trading at $0.3325.

How were Ascend Wellness' earnings last quarter?

Ascend Wellness Holdings, Inc. (OTC:AAWH) issued its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.03. The company earned $141.65 million during the quarter, compared to analysts' expectations of $144.13 million. Ascend Wellness had a negative trailing twelve-month return on equity of 72.18% and a negative net margin of 15.47%.

How do I buy shares of Ascend Wellness?

Shares of AAWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ascend Wellness own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ascend Wellness investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Taiwan Semiconductor Manufacturing (TSM), NVIDIA (NVDA), Teladoc Health (TDOC), JPMorgan Chase & Co. (JPM) and Adobe (ADBE).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 7/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTC
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTC:AAWH
• CIK: 1756390
• Web: www.awholdings.com
• Phone: 646-661-7600
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$48.21 million
• Net Margins: -15.47%
• Pretax Margin: -7.28%
• Return on Equity: -72.18%
• Return on Assets: -9.55%

Debt

• Debt-to-Equity Ratio: 2.61
• Current Ratio: 1.47
• Quick Ratio: 0.80

Sales & Book Value

• Annual Sales: $518.59 million
• Price / Sales: 0.13
• Cash Flow: $0.05 per share
• Price / Cash Flow: 6.64
• Book Value: $0.69 per share
• Price / Book: 0.48

Miscellaneous

• Outstanding Shares: 204,442,000
• Free Float: 166,441,000
• Market Cap: $67.98 million
• Optionable: Not Optionable
• Beta: 1.01